Table 1 A regression model of primary and secondary outcome measures post-treatment (t1) and at a 3-week follow-up (t2), while covarying for baseline scores.
| Â | Beta weights (standardized) | Std error | DF | t value | P value |
|---|---|---|---|---|---|
Clinical symptoms (ADHD-RS) | |||||
Intercept | −0.34 | 0.27 | 22 | 1.23 | 0.0078** |
Baseline score | 0.66 | 0.15 | 20 | 4.53 | 0.0002*** |
Treatment | −0.61 | 0.29 | 20 | −2.11 | 0.047* |
Time | −0.15 | 0.12 | 22 | −1.25 | 0.22 |
Sleep Index total score | |||||
Intercept | −0.44 | 0.413 | 20 | −1.07 | 0.3 |
Baseline score | 0.12 | 0.06 | 19 | 1.87 | 0.08 |
Treatment | 0.48 | 0.24 | 19 | 2 | 0.059 |
Time | −0.14 | 0.23 | 20 | −0.62 | 0.54 |
Sleep Onset Latency score | |||||
Intercept | −0.67 | 0.38 | 22 | −1.78 | 0.9 |
Baseline score | 0.31 | 0.16 | 20 | 1.92 | 0.07 |
Treatment | 0.66 | 0.28 | 20 | 2.37 | 0.02* |
Time | 0.11 | 0.21 | 22 | 0.56 | 0.58 |
Wake-Up score | |||||
Intercept | −0.33 | 0.4 | 22 | −0.82 | 0.42 |
Baseline score | 0.23 | 0.17 | 20 | 1.36 | 0.19 |
Treatment | 0.6 | 0.28 | 20 | 2.13 | 0.046* |
Time | −0.12 | 0.22 | 22 | −0.56 | 0.58 |
RS-EEG measures periodic Beta bandwidth | |||||
Intercept | 0.75 | 0.28 | 56 | 2.72 | 0.009** |
Baseline | 0.06 | 0.09 | 56 | 0.69 | 0.5 |
Treatment | −0.55 | 0.18 | 56 | −3.03 | 0.004** |
Time | −0.33 | 0.16 | 56 | −2.05 | 0.04* |
Aperiodic exponent (Fz) | |||||
Intercept | 0.71 | 0.26 | 21 | 2.74 | 0.01* |
Baseline | 0.58 | 0.17 | 20 | 3.41 | 0.002** |
Treatment | −0.11 | 0.06 | 20 | −1.99 | 0.06 |
Time | −0.02 | 0.04 | 21 | −0.6 | 0.55 |